We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
TIDMGSK
RNS Number : 7621M
GlaxoSmithKline PLC
17 October 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Sir Andrew Witty === ======================== ================================================ b) Position/status Chief Executive Officer === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 October 2016 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP17.00 370.567 (personal contribution) --------- -------------------------------- GBP17.00 370.555 (personal contribution) --------- -------------------------------- GBP17.00 185.720 (personal contribution --------- -------------------------------- GBP17.00 185.720 (personal contribution) --------- -------------------------------- GBP17.00 465.257 (personal contribution) --------- -------------------------------- GBP17.00 370.567 (matching shares) --------- -------------------------------- GBP17.00 370.555 (matching shares) --------- -------------------------------- GBP17.00 185.720 (matching shares) --------- -------------------------------- GBP17.00 185.720(matching shares) --------- -------------------------------- GBP17.00 465.257 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 3155.638 GBP17.00 === ======================== ================================================ e) Date of the transaction 2016-10-13 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Ms E Walmsley === ======================== ================================================ b) Position/status CEO Designate === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 October 2016 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP17.00 81.138 (personal contribution) --------- -------------------------------- GBP17.00 81.138 (personal contribution) --------- -------------------------------- GBP17.00 64.694 (personal contribution) --------- -------------------------------- GBP17.00 64.694 (personal contribution) --------- -------------------------------- GBP17.00 160.210 (personal contribution) --------- -------------------------------- GBP17.00 160.199 (personal contribution) --------- -------------------------------- GBP17.00 81.138 (matching shares) --------- -------------------------------- GBP17.00 81.138 (matching shares) --------- -------------------------------- GBP17.00 64.694 (matching shares) --------- -------------------------------- GBP17.00 64.694 (matching shares) --------- -------------------------------- GBP17.00 160.210 (matching shares) --------- -------------------------------- GBP17.00 160.199 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 1224.146 GBP17.00 === ======================== ================================================ e) Date of the transaction 2016-10-13 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr R G Connor === ======================== ================================================ b) Position/status President, Global Manufacturing & Supply === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 October 2016 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP17.00 72.533 (personal contribution) --------- -------------------------------- GBP17.00 72.521 (personal contribution) --------- -------------------------------- GBP17.00 47.378 (personal contribution) --------- -------------------------------- GBP17.00 47.378 (personal contribution) --------- -------------------------------- GBP17.00 108.850 (personal contribution) --------- -------------------------------- GBP17.00 72.533 (matching shares) --------- -------------------------------- GBP17.00 72.521 (matching shares) --------- -------------------------------- GBP17.00 47.378 (matching shares) --------- -------------------------------- GBP17.00 47.378 (matching shares) --------- -------------------------------- GBP17.00 108.850 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 697.320 GBP17.00 === ======================== ================================================ e) Date of the transaction 2016-10-13 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr S Dingemans === ======================== ================================================ b) Position/status Chief Financial Officer === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 October 2016 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP17.00 175.105 (personal contribution) --------- -------------------------------- GBP17.00 70.032 (personal contribution) --------- -------------------------------- GBP17.00 90.364 (personal contribution) --------- -------------------------------- GBP17.00 90.352 (personal contribution) --------- -------------------------------- GBP17.00 211.571 (personal contribution) --------- -------------------------------- GBP17.00 211.560 (personal contribution) --------- -------------------------------- GBP17.00 175.105 (matching shares) --------- -------------------------------- GBP17.00 70.032 (matching shares) --------- -------------------------------- GBP17.00 90.364 (matching shares) --------- -------------------------------- GBP17.00 90.352 (matching shares) --------- -------------------------------- GBP17.00 211.571 (matching shares) --------- -------------------------------- GBP17.00 211.560 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 1697.968 GBP17.00 === ======================== ================================================ e) Date of the transaction 2016-10-13 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr N Hirons === ======================== ================================================ b) Position/status SVP, Global Ethics & Compliance === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 October 2016 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- ------------------------------- GBP17.00 33.172 (personal contribution) --------- -------------------------------
GBP17.00 33.172 (personal contribution) --------- ------------------------------- GBP17.00 78.227 (personal contribution) --------- ------------------------------- GBP17.00 78.227 (personal contribution) --------- ------------------------------- GBP17.00 33.172 (matching shares) --------- ------------------------------- GBP17.00 33.172 (matching shares) --------- ------------------------------- GBP17.00 78.227 (matching shares) --------- ------------------------------- GBP17.00 78.227 (matching shares) --------- ------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 445.596 GBP17.00 === ======================== ================================================ e) Date of the transaction 2016-10-13 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr S A Hussain === ======================== ================================================ b) Position/status President, Global Pharmaceuticals === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 October 2016 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP17.00 106.388 (personal contribution) --------- -------------------------------- GBP17.00 156.376 (personal contribution) --------- -------------------------------- GBP17.00 184.855 (personal contribution) --------- -------------------------------- GBP17.00 184.855 (personal contribution) --------- -------------------------------- GBP17.00 106.388(matching shares) --------- -------------------------------- GBP17.00 156.376 (matching shares) --------- -------------------------------- GBP17.00 184.855 (matching shares) --------- -------------------------------- GBP17.00 184.855 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 1264.948 GBP17.00 === ======================== ================================================ e) Date of the transaction 2016-10-13 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr D S Redfern === ======================== ================================================ b) Position/status Chief Strategy Officer === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 October 2016 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- ------------------------------- GBP17.00 66.155 (personal contribution) --------- ------------------------------- GBP17.00 66.142 (personal contribution) --------- ------------------------------- GBP17.00 53.158 (personal contribution) --------- ------------------------------- GBP17.00 53.158 (personal contribution) --------- ------------------------------- GBP17.00 99.557 (personal contribution) --------- ------------------------------- GBP17.00 99.557 (personal contribution) --------- ------------------------------- GBP17.00 66.155 (matching shares) --------- ------------------------------- GBP17.00 66.142 (matching shares) --------- ------------------------------- GBP17.00 53.158 (matching shares) --------- ------------------------------- GBP17.00 53.158 (matching shares) --------- ------------------------------- GBP17.00 99.557 (matching shares) --------- ------------------------------- GBP17.00 99.557 (matching shares) --------- ------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 875.454 GBP17.00 === ======================== ================================================ e) Date of the transaction 2016-10-13 === ======================== ================================================ f) Place of the n/a transaction
=== ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================= a) Name Dr M M Slaoui === ======================== =============================================== b) Position/status Chairman, Global Vaccines === ======================== =============================================== c) Initial notification/ Initial notification amendment === ======================== =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================= a) Name GlaxoSmithKline plc === ======================== =============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================= a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument === ======================== =============================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 13 October 2016 on ADSs held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== =============================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- $42.39 115.213 (personal contribution) --------- -------------------------------- $42.39 115.202 (personal contribution) --------- -------------------------------- $42.39 71.742 (personal contribution) --------- -------------------------------- $42.39 71.742 (personal contribution) --------- -------------------------------- $42.39 118.095 (personal contribution) --------- -------------------------------- $42.39 118.095 (personal contribution) --------- -------------------------------- $42.39 115.213 (matching shares) --------- -------------------------------- $42.39 115.202 (matching shares) --------- -------------------------------- $42.39 71.742 (matching shares) --------- -------------------------------- $42.39 71.742 (matching shares) --------- -------------------------------- $42.39 118.095 (matching shares) --------- -------------------------------- $42.39 118.095 (matching shares) --------- -------------------------------- === ======================== =============================================== d) Aggregated information Aggregated volume Price 1220.178 $42.39 === ======================== =============================================== e) Date of the transaction 2016-10-13 === ======================== =============================================== f) Place of the n/a transaction === ======================== =============================================== 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Ms C Thomas === ======================== ================================================ b) Position/status SVP, Human Resources === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 October 2016 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP17.00 82.083 (personal contribution) --------- -------------------------------- GBP17.00 71.552 (personal contribution) --------- -------------------------------- GBP17.00 71.540 (personal contribution) --------- -------------------------------- GBP17.00 145.649 (personal contribution) --------- -------------------------------- GBP17.00 145.649 (personal contribution) --------- -------------------------------- GBP17.00 82.083 (matching shares) --------- -------------------------------- GBP17.00 71.552 (matching shares) --------- -------------------------------- GBP17.00 71.540 (matching shares) --------- -------------------------------- GBP17.00 145.649 (matching shares) --------- -------------------------------- GBP17.00 145.649 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 1032.946 GBP17.00 === ======================== ================================================ e) Date of the transaction 2016-10-13 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr P C Thomson === ======================== ================================================ b) Position/status SVP, Communications & Government Affairs === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
=== ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 October 2016 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- ------------------------------- GBP17.00 49.436 (personal contribution) --------- ------------------------------- GBP17.00 48.598 (personal contribution) --------- ------------------------------- GBP17.00 89.112 (personal contribution) --------- ------------------------------- GBP17.00 49.436 (matching shares) --------- ------------------------------- GBP17.00 48.598 (matching shares) --------- ------------------------------- GBP17.00 89.112 (matching shares) --------- ------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 374.292 GBP17.00 === ======================== ================================================ e) Date of the transaction 2016-10-13 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================= a) Name Mr D E Troy === ======================== =============================================== b) Position/status SVP & General Counsel === ======================== =============================================== c) Initial notification/ Initial notification amendment === ======================== =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================= a) Name GlaxoSmithKline plc === ======================== =============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================= a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument === ======================== =============================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 13 October 2016 on ADSs held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== =============================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ------------------------------- $42.39 46.628 (personal contribution) --------- ------------------------------- $42.39 46.628 (personal contribution) --------- ------------------------------- $42.39 37.123 (personal contribution) --------- ------------------------------- $42.39 37.123 (personal contribution) --------- ------------------------------- $42.39 83.585 (personal contribution) --------- ------------------------------- $42.39 83.585 (personal contribution) --------- ------------------------------- $42.39 46.628 (matching shares) --------- ------------------------------- $42.39 46.628 (matching shares) --------- ------------------------------- $42.39 37.123 (matching shares) --------- ------------------------------- $42.39 37.123 (matching shares) --------- ------------------------------- $42.39 83.585 (matching shares) --------- ------------------------------- $42.39 83.585 (matching shares) --------- ------------------------------- === ======================== =============================================== d) Aggregated information Aggregated volume Price 669.344 $42.39 === ======================== =============================================== e) Date of the transaction 2016-10-13 === ======================== =============================================== f) Place of the n/a transaction === ======================== =============================================== 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Dr P J T Vallance === ======================== ================================================ b) Position/status President, Pharmaceuticals R&D === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 October 2016 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP17.00 146.682 (personal contribution) --------- -------------------------------- GBP17.00 146.671 (personal contribution) --------- -------------------------------- GBP17.00 105.324 (personal contribution) --------- -------------------------------- GBP17.00 105.324 (personal contribution) --------- -------------------------------- GBP17.00 171.329 (personal contribution) --------- -------------------------------- GBP17.00 171.329 (personal contribution) --------- -------------------------------- GBP17.00 146.682 (matching shares) --------- --------------------------------
GBP17.00 146.671 (matching shares) --------- -------------------------------- GBP17.00 105.324 (matching shares) --------- -------------------------------- GBP17.00 105.324 (matching shares) --------- -------------------------------- GBP17.00 171.329 (matching shares) --------- -------------------------------- GBP17.00 171.329 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 1693.318 GBP17.00 === ======================== ================================================ e) Date of the transaction 2016-10-13 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHKDLFFQBFBFBF
(END) Dow Jones Newswires
October 18, 2016 02:00 ET (06:00 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions